Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 11-2021 | 09-2021 | 08-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,162 | 14,047 | N/A | 6,629 | N/A |
| Marketable Securities | 11,951 | 10,794 | N/A | 3,436 | N/A |
| TOTAL | $24,609 | $25,355 | $N/A | $10,317 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 1,519 | 1,524 | 0 | 0 | 0 |
| Intangibles | 2,039 | 2,039 | 0 | 2,039 | 0 |
| Other Non-Current Assets | 84 | 86 | 0 | 279 | 0 |
| TOTAL | $3,642 | $3,649 | $N/A | $2,318 | $N/A |
| Total Assets | $28,251 | $29,004 | $N/A | $12,635 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 996 | 628 | 0 | 498 | 0 |
| TOTAL | $1,027 | $659 | $N/A | $526 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 57 | 59 | 0 | 67 | 0 |
| TOTAL | $57 | $59 | $N/A | $67 | $N/A |
| Total Liabilities | $1,084 | $718 | $N/A | $593 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 470 | N/A | N/A | N/A |
| Common Shares | 3 | 42 | N/A | 25 | N/A |
| Retained earnings | -20,938 | -19,451 | N/A | -16,903 | N/A |
| Other shareholders' equity | -18 | -23 | 0 | 18 | 0 |
| TOTAL | $27,167 | $28,286 | $N/A | $12,042 | $N/A |
| Total Liabilities And Equity | $28,251 | $29,004 | $0 | $12,635 | $0 |